FDA Drug Application (062517) for NYSTATIN by FOUGERA

Back to FDA Applications sponsored by FOUGERA

Application Number062517
Product Number001
FormSUSPENSION;ORAL
Dosage100,000 UNITS/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameNYSTATIN
Active IngredientNYSTATIN

Active IngredientCount
List of drugs with Active Ingredient NYSTATIN18


Back to FDA Applications sponsored by FOUGERA